| Entries |
| Document | Title | Date |
|---|
| 20080228093 | Systems and methods for enhancing cardiac signal features used in morphology discrimination - Methods and devices used to classify cardiac events based on morphological analysis of sensed signals are described. A signal comprising a cardiac signal component and a noise signal component is sensed. The sensed signal is processed to preferentially alter morphology of the cardiac signal component. The altered morphology of the cardiac signal component enhances detection of one or more features of the cardiac signal component. The features of the cardiac signal component are detected and the cardiac event is classified using the detected features. Processing the sensed signal may involve the use of adaptable signal processing parameters. For example, the signal processing parameters may be selected to accentuate one or more desirable features of the cardiac signal component or to mitigate one or more undesirable features of the cardiac signal component. | 09-18-2008 |
| 20090112108 | Q-onset ventricular depolarization detection in the presence of a pacemaker - A method utilizing computer processing for detecting, within a cardiac cycle, the earliest onset of global, Q-onset, ventricular depolarization in the presence of an operating pacemaker. The method, in general terms, features (a) gathering a plurality of ECG-obtained QRS heart-cycles waveforms, (b) identifying and categorizing of evidences and specific timings therein of intrinsic Q-onset and pacemaker spike events, (c) looking in a single, selected QRS waveform, between specific, defined first and second time marks, for the most significant slope change appearing in that waveform, and (d) designating to be the correct Q-onset that event which immediately precedes that slope change. | 04-30-2009 |
| 20090240157 | DEVICE, METHOD AND COMPUTER-READABLE STORAGE MEDIUM FOR ENHANCED SENSE EVENT CLASSIFICATION IN IMPLANTABLE DEVICES BY MEANS OF MORPHOLOGY ANALYSIS - An implantable cardiac device, e.g., a pacemaker, defibrillator, cardioverter or biventricular pacing device, that can sense cardiac electrical signals and accurately classify the sensed events. The device provides a template signal and a test signal originated from an electrogram. The device further transforms at least the test signal into a representation of the test signal for example in numerical format where the sample values of the test signal take the form of integers. The device further determines a correlation between the template and test signals, and classifies the sense events based on the correlation. The electrogram may be an intracardiac electrogram (IEGM), atrial electrogram (AEGM), ventricular electrogram (VEGM), surface electrocardiogram (ECG) or subcutaneous electrogram. | 09-24-2009 |
| 20090281440 | INDUCING PREMATURE ATRIAL CONTRACTIONS FOR THE PURPOSE OF MONITORING AUTONOMIC TONE RISK OF SUDDEN CARDIAC DEATH AND ISCHEMIC EVENTS - Implantable systems, and methods for use therein, perform at least one of a cardiac assessment and an autonomic assessment. Premature atrial contractions (PACs) are induced to thereby cause corresponding premature contractions in the ventricles. Short-term fluctuations in cardiac intervals, that follow the premature contractions in the ventricles caused by the induced PACs, are monitored. At least one of a cardiac assessment and an autonomic assessment is performed based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs. This can include assessing a patient's risk of sudden cardiac death (SCD), assessing a patient's autonomic tone and/or detecting myocardial ischemic events based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs. | 11-12-2009 |
| 20100036271 | FREQUENCY DOMAIN MONITORING OF MYOCARDIAL ELECTRICAL STABILITY - Embodiments of the present invention relate to implantable systems, and methods for use therewith, for monitoring myocardial electrical stability. A patient's heart is paced for a period of time using a patterned pacing sequence that repeats every N beats, and an electrical signal is obtained that is representative of a plurality of consecutive beats of the patient's heart while it is being paced using the patterned pacing sequence that repeats every N beats. Myocardial electrical stability is then analyzed using frequency domain techniques that are tailored to the patterned pacing sequence used to pace the patient's heart. In other embodiments, the patient's heart need not be paced. This abstract is not intended to be a complete description of, or limit the scope of, the invention. | 02-11-2010 |
| 20100121209 | Arrhythmia Discrimination Based on Determination of Rate Dependency - Cardiac systems and methods provide for discriminating between supraventricular tachyarrhythmia and ventricular tachyarrhythmia based on a determination that the patient's supraventricular rhythm exhibits rate dependency. One approach involves determining if a patient's supraventricular rhythm exhibits rate dependent morphology. If the patient's supraventricular rhythm is determined to exhibit rate dependent morphology, an implantable device classifies a detected tachyarrhythmia episode based on one or more templates selected from a plurality of rate-indexed templates stored in the device. Determining if the supraventricular rhythm exhibits rate dependent morphology may also include determining one or more rates at which the rate dependent morphology occurs. | 05-13-2010 |
| 20100191132 | Event Discrimination Using Unipolar and Bipolar Signal Differences - A medical device and associated method discriminate near-field and far-field events by sensing a bipolar signal and a unipolar signal at a tissue site, detecting an event in response to one of the bipolar and unipolar signals, and comparing an event feature determined from the bipolar signal to an event feature determined from the unipolar signal. | 07-29-2010 |
| 20100292596 | System, Method and Computer-Readable Storage Medium For Heart Signal Detection - A system, method and computer-readable storage medium are configured for the detection of electrical signals originating from a human or animal heart. In particular, for monitoring devices, it is desired to obtain electrical signals from a human or animal heart with electrical contacts at the body of an implantable medical device, hence without the need to implant electrical leads to the hearts. Hence, a method, a system and a computer-readable storage medium for detecting electrical signals originating from a human or animal heart is proposed. The method includes the steps of receiving electrical signals in at least two sensing channels, combining the electrical signals for forming a combined channel, extracting a template from the signals of the combined channel, comparing incoming electrical signals with the template, and depending from the result of the comparison, performing at least one of controlling one or more devices and signaling the result. | 11-18-2010 |
| 20100317982 | Module And Device For Discerning Therapeutic Signals from Noise in Physiological Data - A data acquisition module for use in monitoring a plurality of physiological signals is disclosed herein. The data acquisition module may include a first signal processing path for biopotential data, a second signal processing path for therapeutic event data, and a processing unit that receives and processes the data from the first and second signal processing paths. The data acquisition module may further compare identified likely therapeutic events in each of a plurality of psychological signals. | 12-16-2010 |
| 20110004111 | ISCHEMIA DETECTION USING INTRA-CARDIAC SIGNALS - An implanted cardiac rhythm management device is disclosed that is operative to detect myocardial ischemia. This is done by evaluating electrogram features to detect an electrocardiographic change; specifically, changes in electrogram segment during the early part of an ST segment. The early part of the ST segment is chosen to avoid the T-wave. | 01-06-2011 |
| 20110077540 | METHOD AND APPARATUS FOR DETECTING FIBRILLATION USING CARDIAC LOCAL IMPEDANCE - A cardiac rhythm management (CRM) system detects tachyarrhythmia using cardiac local impedance indicative of cardiac local wall motion. A cardiac local impedance signal indicative of an impedance of a cardiac region is sensed by using a pair of bipolar electrodes placed in that cardiac region. Tachyarrhythmia such as VF is detected by analyzing one or more cardiac local impedance signals sensed in one or more cardiac regions. | 03-31-2011 |
| 20110082379 | ANALYZING ECG DATA IN DECIDING ON PATIENT CHEST COMPRESSION TREATMENT - Medical devices, software and methods are provided, for making a decision as to whether to pause patient chest compression treatment in connection with administering electric shock therapy to the patient. The decision is made depending whether signal spikes identified in the ECG data are determined to be QRS complexes, or merely likely impulsive artifact caused by the chest compressions. | 04-07-2011 |
| 20110105926 | HEART RATE VARIABILITY DISTINCTION - Systems, methods and devices for monitoring, analyzing, and processing a patient's heart rate signal for HRV characteristics are described herein. A first heart rate signal is acquired. The first heart rate signal includes at least one indication of an interval duration of cardiac activity. At least one accelerating portion and at least one decelerating portion of the first heart rate signal are identified. An average heart rate signal is acquired. The accelerating portion or the decelerating portion of the first heart rate signal is replaced with the average heart rate signal to produce a second heart rate signal. A frequency spectrum of the second heart rate signal may be obtained and utilized to predict or detect one or more autonomic conditions of a patient. Therapy may initiated or titrated in response to prediction or detection of the autonomic condition. | 05-05-2011 |
| 20110144511 | Cardiac Activation Sequence Monitoring and Tracking - Cardiac monitoring and/or stimulation methods and systems provide monitoring, diagnosis, and defibrillation and/or pacing therapies. A signal processor receives a plurality of composite signals associated with a plurality of sources, performs a source separation, and produces one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences based on the source separation. A method of signal separation involves detecting a change in a characteristic of the cardiac signal vector relative to a baseline. One or more vectors and/or activation sequences may be selected, and information associated with the vectors and/or activation sequences may be stored and tracked. | 06-16-2011 |
| 20110184299 | SYSTEM AND METHOD OF USING AV CONDUCTION TIMING - In an implantable medical device that provides atrial and ventricular pacing in an atrial-based pacing mode, longer periods of time are permitted for intrinsic AV conduction to occur. By monitoring the patient's AV delay under these circumstances, useful information is obtained that can be correlated to other patient conditions or symptoms. | 07-28-2011 |
| 20110201952 | METHOD AND APPARATUS FOR SENSING IMPROVEMENT USING PRESSURE DATA - A method and apparatus for sensing improvement using pressure data. The method and apparatus may be used in an implantable medical device to confirm that an EGM event signifies a true mechanical cardiac activity and not just electrical oversensing. The mechanical activity may be used to create a mechanical marker channel in the implantable medical device. | 08-18-2011 |
| 20110282225 | TECHNIQUES FOR REVIEWING AND ANALYZING IMPLANTABLE MEDICAL DEVICE SYSTEM DATA - A computing device includes a memory device, a communication module, an interface, a processor, a display controller, and an input device. The communication module wirelessly receives a stream of first electrogram waveforms (EGMs) from an implantable medical device (IMD). The interface receives a stream of second EGMs. The processor stores the first and second EGMs and retrieves the stored first and second EGMs. The display controller displays the first and second EGMs together when the first and second EGMs are received. The input device is configured to receive a selection command from a user. The processor retrieves a portion of at least one of the first and second stored EGMs in response to the selection command. The display controller displays the retrieved portion of the at least one of the first and second stored EGMs while the processor concurrently stores the streams of the first and second EGMs. | 11-17-2011 |
| 20110282226 | CARDIAC ANALYSIS SYSTEM FOR COMPARING CLINICAL AND INDUCED VENTRICULAR TACHYCARDIA EVENTS - A cardiac analysis system is provided that includes an implantable medical device (IMD), at least one sensor, and an external device. The IMD has electrodes positioned proximate to a heart that sense first cardiac signals of the heart and associated with a clinical ventricular tachycardia (VT) event and second cardiac signals associated with an induced VT event. The sensor measures first and second cardiac parameters of the heart associated with the clinical and induced VT events, respectively. The external device is configured to receive the first and second cardiac signals associated with the clinical and the induced VT events and the first and second cardiac parameters associated with the clinical and the induced VT events. The external device compares the first and second cardiac signals and compares the first and second cardiac parameters to determine if the clinical and induced VT events are a common type of VT event. | 11-17-2011 |
| 20110295136 | FAR-FIELD SENSING CHANNEL FOR IMPLANTABLE CARDIAC DEVICE - An implantable pacemaker is provided with a far-field sensing channel which requires a reduced refractory period during the time when pacing pulses are delivered as compared with sensing channels using intra-cardiac electrodes. The far-field sensing channel may use the conductive housing of the implantable device or can and an indifferent electrode mounted on the device header as the electrodes for its differential inputs. Such a far-field sensing channel is able to sense activity occurring in either the atria or the ventricles for the purposes of arrhythmia detection and/or capture verification. | 12-01-2011 |
| 20120004564 | DEVICES AND METHOD FOR ACCELEROMETER-BASED CHARACTERIZATION OF CARDIAC SYNCHRONY AND DYSSYNCHRONY - Systems and methods according to the invention employ an acceleration sensor to characterize the synchrony or dyssynchrony of the left ventricle. Patterns of acceleration related to myocardial contraction can be used to assess synchrony or dyssynchrony. Time-frequency transforms and coherence are derived from the acceleration. Information and numerical indices determined from the acceleration time frequency transforms and coherence can be used to find the optimal pacing location for cardiac resynchronization therapy. Similarly, the information can be used to optimize timing intervals including V to V and A to V timing. | 01-05-2012 |
| 20120016250 | SYSTEM AND METHOD FOR DISPLAYING A HISTOGRAM OF CARDIAC EVENTS - Systems, devices and methods are provided for displaying statistical distributions of cardiac events. A device embodiment comprises circuitry adapted to communicate with a medical device that is adapted to acquire data regarding cardiac events occurring at two or more cardiac sites, and display means for displaying a histogram of the data as two or more statistical distributions for the two or more cardiac sites. The histogram includes a number of histogram bins. At least one of the histogram bins includes both a representation for at least a portion of a statistical distribution of a cardiac event for a first cardiac site and a representation for at least a portion of a statistical distribution of a cardiac event for a second cardiac site. Other embodiments are provided herein. | 01-19-2012 |
| 20120022386 | Device and Method To Discriminate Between Supraventricular Tachycardias And Ventricular Arrhythmias - This invention provides a method to discriminate between ventricular arrhythmia and supraventricular tachycardia by detecting an earliest arriving electrical signal following antitachycardia pacing. Also disclosed is an implantable cardiac defibrillator that is capable of simultaneous atrioventricular anti-tachycardia pacing bursts and detecting an earliest arriving electrical signal. The discrimination capability reduces the incidence of inappropriate shocks from dual-chamber implantable cardiac defibrillators to near zero and provides a method to differentially diagnose supraventricular tachycardia from ventricular tachycardia. | 01-26-2012 |
| 20120065529 | METHOD AND SYSTEM FOR QUANTITATIVE MEASURE OF CURRENT OF INJURY DURING LEAD FIXATION - A method and system is provided for measuring current of injury (COI) during lead fixation. The method and system sense cardiac signals from a lead within a chamber of the heart while the lead is in a pre-fixation position and capture a baseline waveform from the cardiac signals while the lead is in the pre-fixation position. The baseline waveform is representative of an interface between the lead and a tissue region proximate a tip of the lead before the lead is actively attached to the tissue region of the heart. The method and system further sense cardiac signals from the lead within the chamber of the heart when the lead is in a post-fixation position and capture a post-fixation waveform from the cardiac signals when the lead is in the post-fixation position. The post-fixation waveform is representative of an interface between the lead and the tissue region proximate the tip of the lead after the lead is actively attached to the tissue region of the heart. The method and system calculate a COI indicator based on an automatic comparison of the baseline and post-fixation waveforms. The method and system further identify a COI feature of interest in the baseline and post-fixation waveforms and calculates at least one of a COI index, a COI area, a COI differential and a COI ratio based on the COI feature of interest in the baseline and post-fixation waveforms. | 03-15-2012 |
| 20120136263 | DETECTION OF RELAXATION ABNORMALITY IN HEART TISSUE - A chronically implanted medical device, connected to a medical electrical lead that includes a sensor, is used to detect diastolic dysfunction. A LV accelerometer signal is sensed through the sensor. Based on the LV accelerometer signal, a determination is made as to whether diastolic dysfunction data exists. | 05-31-2012 |
| 20120197147 | Methods and Devices for Accurately Classifying Cardiac Activity - Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed. | 08-02-2012 |
| 20120226178 | Automatic Cardiac Therapy Advisor With Hidden Markov Model Processing - A method of automatically determining which type of treatment is most appropriate for (or the physiological state of) a patient. The method comprises transforming one or more time domain measurements from the patient into frequency domain data representative of the frequency content of the time domain measurements; processing the frequency domain data to form a plurality of spectral bands, the content of a spectral band representing the frequency content of the measurements within a frequency band; forming a weighted sum of the content of the spectral bands, with different weighting coefficients applied to at least some of the spectral bands; determining the type of treatment (or physiological state) based on the weighted sum. | 09-06-2012 |
| 20120232415 | Method and Devices for Performing Cardiac Waveform Appraisal - Implementations of various technologies described herein are directed toward a sensing architecture for use in cardiac rhythm management devices. The sensing architecture may provide a method and means for certifying detected events by the cardiac rhythm management device. Moreover, by exploiting the enhanced capability to accurately identifying only those sensed events that are desirable, and preventing the use of events marked as suspect, the sensing architecture can better discriminate between rhythms appropriate for device therapy and those that are not. | 09-13-2012 |
| 20120265085 | CARDIAC STIMULATOR - An implantable cardiac stimulator includes a cardioversion/defibrillation unit connectable to at least one ventricular sensing electrode and one ventricular defibrillation electrode, and is designed to generate and deliver cardioversion or defibrillation shocks. A ventricular sensing unit having automatic threshold adaptation is connectable to the ventricular sensing electrode, and is designed to process the signals of the sensing electrode and detect a chamber contraction, and if a chamber contraction is detected, to output a ventricular sensing signal. The ventricular sensing unit processes the signals of the sensing electrode with at least two switchable sensing thresholds wherein after every sense, a VF detection window is started at a first lower sensing threshold; once the VF detection window has passed, a T wave blanking window is activated at an upper second sensing threshold; and once the T wave blanking window has passed, sensing at a second lower threshold is started. | 10-18-2012 |
| 20120283587 | ASSESSING INTRA-CARDIAC ACTIVATION PATTERNS AND ELECTRICAL DYSSYNCHRONY - Techniques for evaluating cardiac electrical dyssynchrony are described. In some examples, an activation time is determined for each of a plurality of torso-surface potential signals. The dispersion or sequence of these activation times may be analyzed or presented to provide variety of indications of the electrical dyssynchrony of the heart of the patient. In some examples, the locations of the electrodes of the set of electrodes, and thus the locations at which the torso-surface potential signals were sensed, may be projected on the surface of a model torso that includes a model heart. The inverse problem of electrocardiography may be solved to determine electrical activation times for regions of the model heart based on the torso-surface potential signals sensed from the patient. | 11-08-2012 |
| 20120289845 | TECHNIQUES FOR DETERMINING MORPHOLOGICAL STABILITY OF CARDIAC CYCLES - A method includes retrieving electrogram (EGM) data for N cardiac cycles from a memory of an implantable medical device. N is an integer greater than 1. The method further include categorizing each of the N cardiac cycles into one of a plurality of categories based on a morphology of the N cardiac cycles and performing comparisons between pairs of the N cardiac cycles. Each of the comparisons between two cardiac cycles includes detecting a mismatch between the two cardiac cycles when the two cardiac cycles are in different categories, and detecting a match between the two cardiac cycles when the two cardiac cycles are in the same category. Additionally, the method includes classifying the rhythm of the N cardiac cycles based on a number of detected matches and detected mismatches. | 11-15-2012 |
| 20130046194 | Arrhythmia Classification - An implantable medical device ( | 02-21-2013 |
| 20130046195 | WIRELESS ECG IN IMPLANTABLE DEVICES - An implantable medical device such as an implantable pacemaker or implantable cardioverter/defibrillator includes a programmable sensing circuit providing for sensing of a signal approximating a surface electrocardiogram (ECG) through implanted electrodes. With various electrode configurations, signals approximating various standard surface ECG signals are acquired without the need for attaching electrodes with cables onto the skin. The various electrode configurations include, but are not limited to, various combinations of intracardiac pacing electrodes, portions of the implantable medical device contacting tissue, and electrodes incorporated onto the surface of the implantable medical device. | 02-21-2013 |
| 20130053715 | METHOD AND SYSTEM FOR ANALYZING THE CARDIAC ACTIVITY OF A PATIENT AND USES THEREOF - This method for analyzing the cardiac activity of a patient are comprises the steps for acquiring ( | 02-28-2013 |
| 20130079651 | EPISODE CLASSIFIER ALGORITHM - The present disclosure is directed to the classification of cardiac episodes using an algorithm. In various examples, an episode classification algorithm evaluates electrogram signal data collected by an implantable medical device. The episode classification algorithm may classify may include a sinus template and a comparison of the electrogram signal to the sinus template. Possible classifications of the cardiac episode may include, for example, unknown, inappropriate, appropriate, supraventricular tachycardia, ventricular tachycardia, ventricular fibrillation or ventricular over-sensing. | 03-28-2013 |
| 20130085403 | ELECTROGRAM SUMMARY - The present disclosure is directed to an electrogram summary. In various examples, a subset of cardiac episodes are selected and displayed based on a set of summary rules. The subset of cardiac episodes includes at least one episode from each of a plurality of episode categories with at least one cardiac episode. In some examples, the order in which the cardiac episodes selected are displayed is based on the set of summary rules. The electrogram summary may include images or information regarding each of the selected cardiac episodes. | 04-04-2013 |
| 20130096446 | Method and System for Differentiating Between Supraventricular Tachyarrhythmia and Ventricular Tachyarrhythmia - A method of differentiating between supraventricular tachyarrhythmia (SVT) and ventricular tachyarrhythmia (VT) is disclosed. A post pacing interval (PPI) is determined based on a biomarker dataset. The post pacing interval is statistically analyzed relative to a threshold to differentiate between SVT and VT. A further method of differentiating between SVT and VT is disclosed. A PPI is determined based on a biomarker dataset. A tachycardia cycle length (TCL) is also determined based on the biomarker dataset. A difference of the PPI minus the TCL is statistically analyzed relative to a threshold to differentiate between SVT and VT. A non-transitory computer readable medium and a system are also disclosed for differentiating between SVT and VT. | 04-18-2013 |
| 20130102912 | NOVEL METHODOLOGY FOR ARRHYTHMIA RISK STRATIFICATION BY ASSESSING QT INTERVAL INSTABILITY - A method of predicting ventricular arrhythmias includes receiving an electrical signal from a subject's heart for a plurality of heart beats, identifying characteristic intervals and heart beat durations of the electrical signal corresponding to each of the plurality of heart beats to provide a plurality of characteristic intervals with corresponding heart beat durations, representing dynamics of the plurality of characteristic intervals as a function of a plurality of preceding characteristic intervals and durations of corresponding heart beats over a chosen period time, assessing a stability of the function over the chosen period of time, and predicting ventricular arrhythmias based on detected instabilities in the dynamics of the characteristic intervals. | 04-25-2013 |
| 20130131527 | METHOD FOR GUIDING AND MONITORING INTRAPERICARDIAL LEAD POSITION FOR AN INTRAPERICARDIAL LEAD SYSTEM - A first cardiac signal associated with an activity of a first implant site of a heart during a cardiac cycle is sensed. A second cardiac signal is sensed using an intrapericardial lead located on an epicardial surface proximate a second implant site of the heart. The second cardiac signal is associated with an activity of the second implant site during the cardiac cycle. A timing delay between the activity of the first implant site and the activity of the second implant site is obtained and analyzed to determine if the intrapericardial lead location is appropriate. The preceding is repeated until an appropriate intrapericardial lead location is determined. Other measurements obtained during implant determine whether the intrapericardial lead location is at or near slow conduction zone and whether the intrapericardial lead is placed at the location having the greatest mechanical delay. Post implant measurements determine whether the intrapericardial lead has migrated. | 05-23-2013 |
| 20130131528 | METHOD OF DETECTING AND CLASSIFYING ARRHYTHMIAS - A method of detecting and classifying cardiac arrhythmias, comprising: receiving a hemodynamic wave signal from at least one hemodynamic sensor by a processor; receiving a cardiac electrical wave signal from a cardiac stimulation device by the processor; integrating, by the processor, the received hemodynamic wave signal and the received cardiac electrical wave signal; determining if a heart arrhythmia is present via examination of the regularity of the hemodynamic signal; and if a heart arrhythmia is determined, classifying the arrhythmia according to a time correlation between the hemodynamic signal and the electrical signal. | 05-23-2013 |
| 20130131529 | SENSING ZONE FOR SPATIALLY RELEVANT ELECTRICAL INFORMATION - Systems and methods are disclosed to determine one or more sensing zones on a body surface for electrocardiographic mapping of a region of interest associated with the heart. The sensing zone can be utilized to facilitate acquisition, processing and mapping of electrical activity for the corresponding region of interest. In other examples, an application-specific arrangement of electrodes can also be provided based on the sensing zone that is determined for the region of interest. | 05-23-2013 |
| 20130261476 | PHRENIC NERVE STIMULATION DETECTION - In an example, a system includes a cardiac pulse generator configured to generate cardiac paces to pace the heart, a sensor configured to sense a physiological signal for use in detecting pace-induced phrenic nerve stimulation where the pace-induced phrenic nerve stimulation is phrenic nerve stimulation induced by electrical cardiac pace signals, and a phrenic nerve stimulation detector configured to analyze the sensed physiological signal to detect PS beats where the PS beats are cardiac paces that induce phrenic nerve stimulation. The detector may be configured to correlate signal data for sensed beat signals to a PS template to detect PS beats, or may be configured to analyze morphological features of sensed beat signals to detect PS beats, or may be configured to detect PS beats using a combination that both correlates signal data for sensed beat signals to a PS template and analyzes morphological features of sensed beat signals. | 10-03-2013 |
| 20130296726 | FREQUENCY ANALYSIS TOOL FOR CARDIAC RESYNCHRONIZATION - Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value. | 11-07-2013 |
| 20130303925 | METHOD, DEVICE AND PROGRAM TO DIFFERENTIATE PACEMAKER-MEDIATED TACHYCARDIA (PMT) FROM TRACKING OF SINUS OR ATRIAL TACHYCARDIA (AT) - Dual chamber pacemaker systems can lead to two forms of pacemaker-facilitated tachycardia—pacemaker-mediated tachycardia (PMT) and tracking of sinus or atrial tachycardia. Current pacemaker algorithms can not always differentiate between these two tachycardias. Various embodiments for differentiating these particular mechanisms of pacemaker-facilitated tachycardia, which is based on the specific termination response to PVARP extension are provided. The response to PVARP extension (V-A-A-V vs V-A-V) is a specific method for differentiation and can be used in conjunction with observations of atrial rate and electrogram morphology (or surface P wave morphology) for distinguishing between the two mechanisms of pacemaker-facilitated tachycardia. | 11-14-2013 |
| 20130324868 | SYSTEMS AND METHODS FOR DETECTING HEALTH DISORDERS - According to some embodiments, a wearable medical device capable of treating a patient presenting with syncope is provided. The wearable medical device includes a memory storing event profile information, a battery, at least one treatment electrode coupled to the battery, at least one processor coupled to the memory and the at least one treatment electrode, and an event manager executed by the at least one processor. The event manager is configured to detect an event associated with syncope; store, in the memory, data descriptive of the event in association with an indication that the data includes data descriptive of a syncopal event; and address the to event. | 12-05-2013 |
| 20140018688 | DEVICE BASED CARDIAC MONITORING AND STRESS TEST - A medical device and associated method establish an occurrence of a premature atrial contraction. The device senses a ventricular signal. A control unit is configured to determine a metric of the ventricular signal during an interval following the premature atrial contraction and detect a change in cardiac stress tolerance in response to the determined metric. | 01-16-2014 |
| 20140039332 | METHOD AND SYSTEM FOR DISCRIMINATION OF VT AND SVT ARRHYTHMIAS - Methods and systems are provided for discriminating heart arrhythmias. The methods and systems include identifying an arrhythmia, recording a predetermined number of beats during the arrhythmia as a base arrhythmia (BA) beats; delivering anti-tachy pacing (ATP) therapy to at least one chamber of the heart. After delivering the ATP therapy, the methods and system record at least one return beat representing cardiac activity following the ATP therapy, determines whether the return beat originated in a reference chamber of the heart, compares a morphology of the return beat to a morphology of the BA beat; and declares a VT or SVT based on the comparing operation. | 02-06-2014 |
| 20140039333 | SYSTEMS AND METHODS FOR DETECTING MECHANICAL DYSSYNCHRONY AND STROKE VOLUME FOR USE WITH AN IMPLANTABLE MEDICAL DEVICE EMPLOYING A MULTI-POLE LEFT VENTRICULAR LEAD - Techniques are provided for use with an implantable medical device for evaluating mechanical cardiac dyssynchrony based impedance (Z) measured along different vectors between an electrode in the right ventricle (RV) and various electrodes of a multi-pole left ventricle (LV) lead. | 02-06-2014 |
| 20140039334 | INTERNET-BASED SYSTEM FOR CHARACTERIZING PATIENTS UNDERGOING AN ELECTROPHYSIOLOGY PROCEDURE - The invention provides a system for evaluating a patient featuring: 1) an ECG-measuring system connected to the patient and configured to sense ECG information from the patient; 2) a data-acquisition system interfaced to a vital sign-monitoring system configured to sense vital sign information from the patient during an electro-physiology (EP) procedure; and 3) an external software system interfaced to both systems. The external software system includes a first software interface that receives ECG information measured from the patient by the ECG-measuring system, and a second software interface that receives vital sign and EP-related information from the data-acquisition system measured from the patient during an EP procedure. A database stores physiological and EP-related information measured from the patient before, during, and after the EP procedure. And an algorithm interfaced with the database determines an efficacy of the EP procedure by collectively analyzing information measured during each of these phases. | 02-06-2014 |
| 20140046204 | METHODS AND DEVICES FOR ACCURATELY CLASSIFYING CARDIAC ACTIVITY - Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed. | 02-13-2014 |
| 20140094708 | APPARATUS FOR DETERMINING POSSIBILITY OF RETURN OF SPONTANEOUS CIRCULATION - An apparatus for determining a possibility of return of spontaneous circulation, includes: an electrocardiogram acquiring unit acquiring electrocardiogram waveform data from a subject in a cardiac arrest condition during chest compression applied to the subject; a bandpass filter unit allowing only a frequency component in a vicinity of a frequency of a P wave of the electrocardiogram waveform to pass through the bandpass filter unit; a resuscitation possibility determining unit determining whether an output of the bandpass filter unit exceeds a predetermined value or not, and determining that there is the possibility of return of spontaneous circulation when the output exceeds the predetermined value; and an outputting unit outputting a result of determination related to the possibility of return of spontaneous circulation. | 04-03-2014 |
| 20140114203 | SYSTEMS AND METHODS FOR OFF-LINE REPROGRAMMING OF IMPLANTABLE MEDICAL DEVICE COMPONENTS TO REDUCE FALSE DETECTIONS OF CARDIAC EVENTS - Techniques are provided for use by implantable medical devices such as pacemakers or by external systems in communication with such devices. An intracardiac electrogram (IEGM) is sensed within a patient in which the device is implanted using a cardiac signal sensing system. Cardiac events of interest such as arrhythmias, premature atrial contractions (PACs), premature ventricular contractions (PVCs) and pacemaker mediated tachycardias (PMTs) are detected within the patient using event detection systems and then portions of the IEGM representative of the events of interest are recorded in device memory. Subsequently, during an off-line or background analysis, the recorded IEGM data is retrieved and analyzed to identify false detections. In response to false detections, the cardiac signal sensing systems and/or the event detection systems of the implantable device are selectively adjusted or reprogrammed to reduce or eliminate any further false detections, including false-positives or false-negatives. Various adaptive reprogramming techniques are described. | 04-24-2014 |
| 20140135638 | Monitoring Physiological Signals During External Electrical Stimulation - Electrodes and circuitry for monitoring and stimulating the exterior of the human body, comprising delivering stimulation pulses to stimulation electrodes applied to the exterior of the body, detecting an electrical potential at monitoring electrodes applied to the exterior of the body, positioning at least a first and second monitoring electrode at locations at which an electrical artifact caused by the electrical stimulation pulses is substantially cancelled in a signal formed from the electrical potentials detected at the first and second monitoring electrodes. | 05-15-2014 |
| 20140148717 | METHOD AND SYSTEM FOR ARRHYTHMIA DISCRIMINATION - A method and system for discriminating ventricular arrhythmia is disclosed. In an embodiment, the method can include implementing an arrhythmia discrimination algorithm that can discriminate between supraventricular tachycardia (SVT) and ventricular tachycardia (VT) using at least one programmable parameter programmed to a first value. The method can include analyzing an SVT event, where analyzing the SVT event can include sensing a physiological signal during the SVT event and identifying characteristics of the sensed physiological signal. The method can further include analyzing a cardiac signal to classify the cardiac signal as either an SVT or a VT using the arrhythmia discrimination algorithm with the programmable parameter (programmed to a second value. The second value can be determined from the identified characteristics of the sensed physiological signal. | 05-29-2014 |
| 20140180149 | IMPLANTABLE MYOCARDIAL ISCHEMIA DETECTION, INDICATION AND ACTION TECHNOLOGY - One embodiment enables detection of MI/I and emerging infarction in an implantable system. A plurality of devices may be used to gather and interpret data from within the heart, from the heart surface, and/or from the thoracic cavity. The apparatus may further alert the patient and/or communicate the condition to an external device or medical caregiver. Additionally, the implanted apparatus may initiate therapy of MI/I and emerging infarction. | 06-26-2014 |
| 20140221857 | ADAPTIVE WAVEFORM APPRAISAL IN AN IMPLANTABLE CARDIAC SYSTEM - Methods and implantable devices for cardiac signal analysis. The methods and devices make use of waveform appraisal techniques to distinguish event detections into categories for suspect events and waveform appraisal passing events. When adjustments are made to the data entering analysis for waveform appraisal, the waveform appraisal thresholds applied are modified as well. For example, when the data analysis window for waveform appraisal changes in length, a waveform appraisal threshold is modified. Other changes, including changes in sensing characteristics with which waveform appraisal operates may also result in changes to the waveform appraisal threshold including changes in gain, sensing vector, activation of other devices, implantee posture and other examples which are explained. | 08-07-2014 |
| 20140257120 | METHODS AND DEVICES FOR ACCURATELY CLASSIFYING CARDIAC ACTIVITY - Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis. | 09-11-2014 |
| 20140296725 | METHOD AND APPARATUS FOR ADJUSTING CARDIAC EVENT DETECTION THRESHOLD BASED ON DYNAMIC NOISE ESTIMATION - An implantable cardiac rhythm management (CRM) device includes a sensing and detection circuit that senses at least one cardiac signal and detects cardiac electrical events from the sensed cardiac signal using a detection threshold that is adjusted based on a dynamic noise estimation. The sensed cardiac signal is filtered to produce a filtered cardiac signal having a signal frequency band and a noise signal having a noise frequency band. The noise frequency band is substantially different from the signal frequency band. A dynamic noise floor is produced based on the noise signal and used as the minimum value for the detection threshold. A cardiac electrical is detected when the amplitude of the filtered cardiac signal exceeds the detection threshold. | 10-02-2014 |
| 20140309543 | DEVICES, SYSTEMS AND METHODS TO PERFORM ARRHYTHMIA DISCRIMINATION BASED ON THE ATRIAL AND VENTRICULAR ACTIVATION TIMES - Described herein are implantable systems and devices, and methods for use therewith, that can be used to perform arrhythmia discrimination based on activation times. A plurality of different sensing vectors are used to obtain a plurality of IEGMs that collectively enable electrical activations to be detected in the left atrial (LA) chamber, the right atrial (RA) chamber, and at least one ventricular chamber of a patient's heart. For each of a plurality of cardiac cycles, there is a determination, based on the plurality of obtained IEGMs, of an LA activation time, an RA activation time, and a ventricular activation time. Arrhythmia discrimination is then performed based on the determined activation times. | 10-16-2014 |
| 20140323892 | SYSTEMS, METHODS, AND INTERFACES FOR IDENTIFYING EFFECTIVE ELECTRODES - Systems, methods, and interfaces are described herein for identification of effective electrodes to be used in sensing and/or therapy. Two or more portions of a signal monitored using an electrode may be compared to determine whether the electrode is effective. The two or more portions may correspond to the same portion or window of a cardiac cycle. Further, signals from a first electrode and from a second electrode located proximate the first electrode may be compared to determine whether one or both of the electrodes are effective. | 10-30-2014 |
| 20140323893 | SYSTEMS, METHODS, AND INTERFACES FOR IDENTIFYING EFFECTIVE ELECTRODES - Systems, methods, and interfaces are described herein for identification of effective electrodes to be used in sensing and/or therapy. Two or more portions of a signal monitored using an electrode may be compared to determine whether the electrode is effective. The two or more portions may correspond to the same portion or window of a cardiac cycle. Further, signals from a first electrode and from a second electrode located proximate the first electrode may be compared to determine whether one or both of the electrodes are effective. | 10-30-2014 |
| 20140350420 | IMPLANTABLE CARDIAC SYSTEMS WITH BASELINE CORRECTION IN RESPONSE TO NOISE DETECTION - Implantable cardiac devices and methods of their use. A method of operation in an implantable cardiac device may include steps for characterizing detected events as noise or not noise, identifying a set of consecutive noise events or a threshold quantity of noise events in a set period of time and declaring a noisy series to have occurred. In response to the declaration of a noisy series, the method initiates a baseline correction algorithm. Devices for performing such methods are also disclosed. | 11-27-2014 |
| 20150032014 | DETERMINING ONSETS AND OFFSETS OF CARDIAC DEPOLARIZATION AND REPOLARIZATION WAVES - An exemplary computer-implemented method is disclosed for detection of onset of depolarization on far-field electrograms (EGMs) or electrocardiogram (ECG)- or ECG-like signals. The method includes determining a baseline rhythm using a plurality of body-surface electrodes. The baseline rhythm includes an atrial marker and a ventricular marker. A pre-specified window is defined as being between the atrial marker and the ventricular marker. A low pass filter is applied to a signal within the window. A rectified slope of the signal within the window is determined. A determination is made as to whether a time point (t1) is present such that the rectified slope exceeds 10% of a maximum value of the rectified slope. A point of onset of a depolarization complex in the signal is determined. The point of onset occurs at a largest curvature in the signal within the window. | 01-29-2015 |
| 20150057558 | LEADLESS PACEMAKER WITH TRIPOLAR ELECTRODE - A leadless implantable medical device comprises a first electrode configured to deliver electrical pacing energy, a second electrode configured to sense intrinsic electrical cardiac activity, and a third electrode configurable to both deliver electrical pacing energy and sense intrinsic electrical cardiac activity. The first and third electrodes are used for delivering electrical pacing energy and the second and third electrodes are used to sense intrinsic electrical cardiac activity. None of the first, second and third electrodes are incorporated into a lead. | 02-26-2015 |
| 20150073286 | Method and Apparatus for Optimization of Cardiac Resynchronization Therapy Using Vectorcardiograms Derived from Implanted Electrodes - A cardiac resynchronization pacemaker and a method of adjusting the pacemaker. The method includes deriving a vectorcardiogram from implanted electrodes (D-VCG), analyzing the D-VCG, deriving optimal CRT pacing parameters from the analysis of the D-VCG, and adjusting the CRT pacemaker according to the derived parameters. The pacemaker may include a processor configured to perform the method. | 03-12-2015 |
| 20150088016 | Mobile Device Control - A system includes a processor coupled to a memory, the processor and memory configured to determine a proficiency level of a user of a rescue application based on stored data indicative of the user's proficiency level, and based on the user's proficiency level, select a level of operation for the rescue application. The rescue application is executed on a mobile device and configured to control operation of an AED. Each of multiple levels of operation for the rescue application allows the user a different degree of control over the operation of the AED. The processor and memory are configured to present, to the user, a set of instructions associated with the selected level of operation; and to enable control of the AED according to the selected levels of operation. A different set of instructions is associated with each of the multiple levels. | 03-26-2015 |
| 20150088017 | Method and Apparatus for Monitoring Arrythmogenic Effects of Medications Using an Implantable Device - An implantable device and method for monitoring changes in the risk of arrhythmia induced by medications. The implantable device monitors risk of arrhythmia by analyzing an aspect of T-wave morphology to generate a metric of transmural dispersion of repolarization (“TDR”) as a proxy for the risk of arrhythmia. The implantable device generates an index of change in the risk of arrhythmia by comparing values of the metric of TDR obtained for different time periods. The implantable device generates a warning if the change in risk of arrhythmia is outside acceptable limits. The implantable device can also communicate with other devices to correlate changes in risk of arrhythmia with medications taken by the patient. | 03-26-2015 |
| 20150094604 | ELECTROCARDIOGRAM IDENTIFICATION - A defibrillating system includes a processor coupled to a memory. The processor and the memory are configured to identify a treatment event associated with treatment of a victim with the defibrillating system, and transmit a representation of a portion of an ECG signal associated with the identified treatment event. In some cases, the processor and the memory are configured to identify the portion of the ECG signal associated with the identified treatment event. In some cases, the portion of the ECG signal is of a predetermined length of time having a start time and an end time based on a time associated with the identified treatment event. | 04-02-2015 |
| 20150105680 | METHOD FOR DISCRIMINATING BETWEEN VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS - The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not. | 04-16-2015 |
| 20150112216 | METHOD AND APPARATUS FOR CARDIAC FUNCTION MONITORING - A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining the change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is an increase in the pacing threshold during delivery of the adjusted pacing therapy, and determine hypokalemia in response to the increase in the pacing threshold during delivery of the adjusted pacing therapy being present. | 04-23-2015 |
| 20150112217 | METHOD AND APPARATUS FOR CARDIAC FUNCTION MONITORING - A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining whether there is a change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is a decrease in the pacing threshold during delivery of the adjusted pacing therapy, and determine hyperkalemia in response to the decrease in the pacing threshold during delivery of the adjusted pacing therapy being present. | 04-23-2015 |
| 20150133805 | Evolving Serial Comparison System with Critical Alert Notifications - A system for serial comparison of physiological data, including: a controller; a user interface; and a memory including instructions that, when executed by the controller, perform the steps of: receiving from a first data source a current clinical report including first set of physiological data of a patient and computer-generated first interpretive statements; accessing, from the patient file in a patient database, a previous clinical report including a second set of physiological data of the patient and physician-edited interpretive statements; mapping the physician-edited interpretive statements into one or more codes of a structured data format, wherein each code uniquely identifies a medical state; performing a serial comparison between the current clinical report and the previous clinical report to generate serial comparison interpretive statements; providing to a user, via the user interface, the serial comparison interpretive statements; and receiving, via the user interface, current physician-edited interpretive statements. | 05-14-2015 |
| 20150148696 | Electrocardiogram Pace Pulse Detection and Analysis - Data is received characterizing an electrocardiogram (ECG) measured from a patient having a pacemaker. The pacemaker can intermittently provide a pace to a heart of the patient. By comparing at least a portion of the received data to a template a pace pulse can be detected from at least a portion of the received data. The template comprises one or more pace pulses measured from the patient. The template is modified, at least in part, by the detected pace pulse to update the template. Data characterizing the detected pace pulse is provided. Related apparatus, systems, techniques and articles are also described. | 05-28-2015 |
| 20150305640 | IMPLANTABLE MEDICAL DEVICE (IMD) SENSING MODIFICATIONS RESPONSIVE TO DETECTED PACING PULSES - In situations in which an implantable medical device (IMD) (e.g., an extravascular ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the IMD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the IMD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the IMD includes a pace pulse detector that detects, based on the processing of sensed electrical signals, delivery of a pacing pulse from a second implantable medical device and blank, based on the detection of the pacing pulse, the sensed electrical signal to remove the pacing pulse from the sensed electrical signal. | 10-29-2015 |
| 20150305641 | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) TACHYARRHYTHMIA DETECTION MODIFICATIONS RESPONSIVE TO DETECTED PACING - An implantable medical device comprises a sensing module configured to obtain electrical signals from one or more electrodes and a control module configured to process the electrical signals from the sensing module in accordance with a tachyarrhythmia detection algorithm to monitor for a tachyarrhythmia. The control module detects initiation of a pacing train delivered by a second implantable medical device, determines a type of the detected pacing train, and modifies the tachyarrhythmia detection algorithm based on the type of the detected pacing train. | 10-29-2015 |
| 20150305642 | PACE PULSE DETECTOR FOR AN IMPLANTABLE MEDICAL DEVICE - In situations in which an implantable medical device (e.g., a subcutaneous ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the subcutaneous ICD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the ICD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the ICD includes a first pace pulse detector configured to obtain a sensed electrical signal and analyze the sensed electrical signal to detect a first type of pulses having a first set of characteristics and a second pace pulse detector configured to obtain the sensed electrical signal and analyze the sensed electrical signal to detect a second type of pulses having a second set of characteristics. | 10-29-2015 |
| 20150313483 | METHOD, IMPLANTABLE MEDICAL DEVICE, AND SYSTEM FOR DETERMINING THE CONDITION OF A HEART VALVE - An implantable medical device has an impedance processor for determining atrial impedance data reflective of the cardiogenic impedance of an atrium of a heart during diastole and/or systole of heart cycle. Ventricular impedance data reflective of the cardiogenic impedance of a ventricle during diastole and/or systole are also determined. The determined impedance data are processed by a representation processor for estimating a diastolic and/or a systolic atrial impedance representation and a diastolic and/or a systolic ventricular impedance representation. A condition processor determines the presence of any heart valve malfunction, such as valve regurgitation and/or stenosis, of at least one heart valve based on the estimated atrial and ventricular impedance representations. | 11-05-2015 |
| 20150335244 | Monitor Defibrillator Telemedicine Server - A system and device ( | 11-26-2015 |
| 20150335259 | SYSTEM AND METHODS FOR ASSESSING HEART FUNCTION - Systems and methods can be used to provide an indication of heart function, such as an indication of mechanical function or hemodynamics of the heart, based on electrical data. For example, a method for assessing a function of the heart can include determining a time-based electrical characteristic for a plurality of points distributed across a spatial region of the heart. The plurality of points can be grouped into at least two subsets of points based on at least one of a spatial location for the plurality of points or the time-based electrical characteristics for the plurality of points. An indication of synchrony for the heart can be quantified based on relative analysis of the determined time-based electrical characteristic for each of the at least two subsets of points. | 11-26-2015 |
| 20160007873 | POWER SAVING COMMUNICATION FOR MEDICAL DEVICES | 01-14-2016 |
| 20160015287 | LEADLESS PACING SYSTEM INCLUDING SENSING EXTENSION - A leadless pacing system includes a leadless pacing device and a sensing extension extending from a housing of the leadless pacing device. The sensing extension includes one or more electrodes with which the leadless pacing device may sense electrical cardiac activity. The one or more electrodes of the sensing extension may be carried by a self-supporting body that is configured to passively position the one or more electrodes proximate or within a chamber of the heart other than the chamber in which the LPD is implanted. | 01-21-2016 |
| 20160015322 | LEADLESS PACING SYSTEM INCLUDING SENSING EXTENSION - A leadless pacing system includes a leadless pacing device and a sensing extension extending from a housing of the leadless pacing device. The sensing extension includes one or more electrodes with which the leadless pacing device may sense electrical cardiac activity. The one or more electrodes of the sensing extension may be carried by a self-supporting body that is configured to passively position the one or more electrodes proximate or within a chamber of the heart other than the chamber in which the LPD is implanted. | 01-21-2016 |
| 20160045130 | METHODS AND IMPLANTABLE DEVICES FOR DETECTING ARRHYTHMIA - Methods and devices for accelerating the identification of arrhythmias in implantable medical devices. Following identification of a potential arrhythmia onset condition, such as by identifying a plurality of closely coupled detected events, a retrospective pattern recognition analysis is performed to seek out a possible onset comprising a Torsades de Pointes. Although the methods and devices are designed to target Torsades de Pointes, wider application to other arrhythmia onset conditions is contemplated as well. | 02-18-2016 |
| 20160045131 | CARDIAC RATE TRACKING IN AN IMPLANTABLE MEDICAL DEVICE - Self-correlation enhancements and implementations are described. In particular, certain examples demonstrate the use of a tracking mechanism to identify and/or confirm cardiac rate using data from iterative self-correlation performed at intervals over time. This may enable the interpolation of cardiac rate in an implantable medical device when data is insufficient, and may provide confidence in cardiac rate analyses. | 02-18-2016 |
| 20160045136 | CALCULATION OF SELF-CORRELATION IN AN IMPLANTABLE CARDIAC DEVICE - Self-correlation enhancements and implementations are described. In particular, certain examples demonstrate the analytical tools to reduce the computational burden of generating a self-correlation function within an implantable medical device. Peak selector and tracking analysis are also included as secondary elements for identifying and generating confidence in rate estimates based on the self-correlation function. The approach may enable an alternative calculation of cardiac rate in an implantable medical device as a stand-alone rate detector or as a double-check of other rate calculations. | 02-18-2016 |
| 20160051826 | Intra Cardiac Device, System And Methods - An intra cardiac device is disclosed. The device comprises means for transforming kinetic energy from heart tissue movement into electrical energy in use, from which electrical energy information in respect of heart function is obtainable. Furthermore, a system is disclosed, comprising one such intra cardiac device and at least one receiver, wherein the intra cardiac device comprises means of communication, through which said at least one device communicates with the receiver(s) wirelessly. In this way energy from heart movement provides self contained intra cardiac devices for conveniently monitoring or stimulating a patient's heart. | 02-25-2016 |
| 20160081573 | FREQUENCY ANALYSIS TOOL FOR CARDIAC RESYNCHRONIZATION - Systems and methods are provided for evaluating an expected effectiveness of cardiac resynchronization therapy. Electrocardiogram (ECG) data is received as at least one ECG lead from a set of electrodes. A frequency spectrum representing the ECG data is generated via a Fourier transform. At least one predictor value is extracted from the calculated frequency spectrum. A fitness parameter, representing the expected effectiveness of cardiac resynchronization, is determined from at least the extracted predictor value. | 03-24-2016 |
| 20160081619 | SENSOR GUIDED RESPONSE TO ANTI-ARRHYTHMIC CHANGES - A patient's response to anti-arrhythmic drug changes can be monitored using cardiac activity information, such as using cardiac electromechanical time intervals adjusted for heart rate. A cardiac electromechanical time interval can include an R-S2 interval or an S2-R interval. Tracking changes in cardiac electromechanical time intervals adjusted for heart rate can be used to provide information about a patient, including anti-arrhythmic drug effect information and patient condition information. | 03-24-2016 |
| 20160113534 | ATRIAL ARRHYTHMIA DETECTION DURING INTERMITTENT INSTANCES OF VENTRICULAR PACING IN A CARDIAC MEDICAL DEVICE - A method and medical device for determining a cardiac event that includes sensing a cardiac signal, determining a predetermined number of sensed cardiac events in response to the sensed cardiac signal, determining a plurality of sensed event windows in response to the predetermined number of the sensed cardiac events, determining, for each of the plurality of sensed event windows, whether a number of paced events is less than a paced event threshold, determining whether intervals within the sensed event windows having a number of paced events less than the paced event threshold are greater than an interval threshold, determining an interval difference factor for each of the plurality of windows having intervals less than the interval threshold, and determining the cardiac event in response to the interval difference factors determined for each of the plurality of windows. | 04-28-2016 |
| 20160113537 | ATRIAL ARRHYTHMIA DETECTION DURING VENTRICULAR PACING IN A CARDIAC MEDICAL DEVICE - A method and medical device for determining a cardiac event that includes determining classification factors in response to a sensed cardiac signal, and classifying the cardiac signal as one of a plurality of cardiac events in response to the determined classification factors. The classification factors include determining sensed event windows having predetermined interval pairs during a predetermined time period, determining whether a number of the determined sense event windows is less than an interval pair threshold, determining whether a number of intervals occurring during the predetermined time period and not within the sensed event windows that are less than a predetermined interval threshold is greater than a sensed interval threshold, determining whether a predetermined number of intervals occurring during the predetermined time period and not within the sensed event windows are less than a short interval count threshold, determining whether a predetermined number of intervals occurring during the predetermined time period that are either within the sensed event windows or not within the sensed event windows that are paced events is greater than a paced event threshold, and determining whether oversensing detection occurred during the predetermined event time period. | 04-28-2016 |
| 20160113577 | ATRIAL ARRHYTHMIA EPISODE DETECTION IN A CARDIAC MEDICAL DEVICE - A method and medical device for determining a cardiac episode that includes sensing a cardiac signal, identifying the signal sensed during a predetermined time interval as one of a cardiac event, a non-cardiac event, and an unclassified event, determining a number of identified cardiac events, determining a number of identified unclassified events, and determining whether the cardiac episode is occurring in response to the number of identified cardiac events being greater than a cardiac event count threshold and the number of identified unclassified events being less than an unclassified event count threshold. | 04-28-2016 |
| 20160113586 | FILTERING NOISE FROM A SIGNAL SUBJECTED TO BLANKING - The disclosure describes techniques and systems for filtering noise from a physiological signal. In one example, one or more processors are configured to receive a signal indicative of physiological activity of a patient, wherein the signal comprises noise at one or more frequencies, and filter the noise from the signal according to a noise rejection model, wherein the noise rejection model predicts the noise at the one or more frequencies. The one or more processors may also be configured to, responsive to initiation of a blanking period for the signal, advance the noise rejection model in time during the blanking period, and, responsive to termination of the blanking period, filter, based on the noise rejection model advanced in time, the noise at the one or more frequencies from the signal. | 04-28-2016 |
| 20160114162 | SENSING AND ATRIAL-SYNCHRONIZED VENTRICULAR PACING IN AN INTRACARDIAC PACEMAKER - An intracardiac pacemaker is configured to filter a raw cardiac electrical signal received by the pacemaker to produce a filtered cardiac electrical signal, analyzes the filtered cardiac electrical signal to establish cardiac event sensing criteria that discriminate P-waves from T-waves and R-waves all present in the raw cardiac electrical signal, and sense the P-waves from the filtered cardiac electrical signal when the established cardiac event sensing criteria are met. Sensed P-waves may be used for controlling atrial-synchronized ventricular pacing delivered by the pacemaker. | 04-28-2016 |
| 20160128630 | Methods and Devices for Accurately Classifying Cardiac Activity - Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis. | 05-12-2016 |
| 20160166167 | SYSTEM AND METHOD FOR TARGETING HEART RHYTHM DISORDERS USING SHAPED ABLATION | 06-16-2016 |
| 20160174896 | SYSTEM FOR ANALYZING ENERGY DELIVERED TO ECG DEVICE FROM DEFIBRILLATOR | 06-23-2016 |
